ATXI
Avenue Therapeutics Inc
Halal Rating :
Last Price
$1.89
Last updated:
Market Cap
-
7D Change
-0.53%
1 Year Change
1230.99%
Company Overview
Industries
Exchange
Next Earnings Date
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of various conditions. The company is currently developing IV Tramadol for post-operative acute pain management. They are in the clinical development stage and do not currently generate revenue from product sales.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Avenue Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.